Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Rex Eupseiphos's Profile
Displaying 101-150 of 156 result(s).
CYDY CytoDyn Inc
05/28/2020 10:09:02 AM
the sooner the better only if the n
CYDY CytoDyn Inc
05/27/2020 2:06:23 PM
"some say" + pretty much any crazy (1)
CYDY CytoDyn Inc
05/26/2020 3:24:53 PM
enrollment is the biggest issue for
CYDY CytoDyn Inc
05/26/2020 3:21:51 PM
Oh, that's awesome, FIREwithCYDY. G
CYDY CytoDyn Inc
05/26/2020 2:05:50 PM
I don't think that's right, but I'm
CYDY CytoDyn Inc
05/26/2020 1:19:33 PM
yep, enrollment is key. I thought t
CYDY CytoDyn Inc
05/26/2020 12:16:57 AM
I'm thinking it's 75-25 for reachin (2)
CYDY CytoDyn Inc
05/25/2020 10:50:23 PM
Worst case? August 1 for mild/mediu (2)
CYDY CytoDyn Inc
05/25/2020 4:49:46 PM
Why are we on the to invest or not (3)
CYDY CytoDyn Inc
05/25/2020 11:28:38 AM
itoliumab: "A few patients have bee (2)
CYDY CytoDyn Inc
05/24/2020 1:03:58 PM
He's wrong. Survival rates among EC (1)
CYDY CytoDyn Inc
05/24/2020 1:01:11 PM
The 24.5% "revision" is misleading. (1)
CYDY CytoDyn Inc
05/24/2020 12:24:52 PM
Not at all. The point is that we ar
CYDY CytoDyn Inc
05/24/2020 11:58:23 AM
An assumption of the two-sample tes (3)
CYDY CytoDyn Inc
05/24/2020 1:16:13 AM
Well, 11 patients are not a whole l (3)
CYDY CytoDyn Inc
05/23/2020 6:30:31 PM
My P.S. just means that TechGuru's
CYDY CytoDyn Inc
05/23/2020 6:28:08 PM
Zero chance of completed trial resu (5)
CYDY CytoDyn Inc
05/23/2020 6:12:46 PM
I agree that 5/10 survival from the (1)
CYDY CytoDyn Inc
05/23/2020 2:08:28 PM
our patients survive by far above s
CYDY CytoDyn Inc
05/23/2020 1:13:59 AM
I agree, but I listened to Dr Yo an
CYDY CytoDyn Inc
05/22/2020 9:55:26 PM
EUA would be interesting too (altho
CYDY CytoDyn Inc
05/22/2020 3:25:23 PM
what a horrific story of the inhere (3)
CYDY CytoDyn Inc
05/22/2020 1:24:16 PM
"Plutarhcy" and "oligarchy" are abs (2)
CYDY CytoDyn Inc
05/21/2020 2:34:53 PM
or he misspoke last week maybe? He
CYDY CytoDyn Inc
05/21/2020 9:32:10 AM
I don't think he misspoke because h
CYDY CytoDyn Inc
05/21/2020 2:06:41 AM
Interesting new paper on the possib (4)
CYDY CytoDyn Inc
05/20/2020 4:23:33 PM
Didn't GILD have two placebo arms b
CYDY CytoDyn Inc
05/20/2020 1:11:43 PM
stop loss can get you killed by sho (2)
CYDY CytoDyn Inc
05/19/2020 11:04:26 PM
tocilizumab has more serious side e (4)
CYDY CytoDyn Inc
05/19/2020 9:51:04 PM
amazing...this guy doesn't seem to (2)
CYDY CytoDyn Inc
05/19/2020 9:14:33 AM
Ha! You're of course right...and I (1)
CYDY CytoDyn Inc
05/19/2020 8:53:43 AM
Hopefully the dramatic "results" re (1)
CYDY CytoDyn Inc
05/18/2020 11:02:26 PM
That's funny! Dr P ain't going anyw
CYDY CytoDyn Inc
05/18/2020 7:47:50 PM
The short attacks seem to have pete
CYDY CytoDyn Inc
05/18/2020 3:09:36 PM
oh for crying out loud! you say you (1)
CYDY CytoDyn Inc
05/18/2020 2:37:19 PM
Do you suppose Dr. P gets samples a
CYDY CytoDyn Inc
05/18/2020 10:11:08 AM
Dr P is sort of an add-on to the tr (9)
CYDY CytoDyn Inc
05/17/2020 3:06:54 PM
Baricitinib? tocilizumab?
CYDY CytoDyn Inc
05/13/2020 1:55:33 PM
NP seems to bring EVERYTHING up. Wi
CYDY CytoDyn Inc
05/13/2020 1:45:42 PM
If it actually happened it would be
CYDY CytoDyn Inc
05/13/2020 9:52:34 AM
Two things removed a ton of doubts
CYDY CytoDyn Inc
05/13/2020 12:26:41 AM
assuming the results are good!
CYDY CytoDyn Inc
05/13/2020 12:10:28 AM
"How is it that the person in charg (7)
CYDY CytoDyn Inc
05/12/2020 8:07:36 PM
...looks like an outline for Wed we
CYDY CytoDyn Inc
05/11/2020 6:36:06 PM
The patients in Patterson's study w
CYDY CytoDyn Inc
05/11/2020 6:30:08 PM
Understood...a massive project. It
CYDY CytoDyn Inc
05/11/2020 6:25:04 PM
You are right. I was hoping for com
CYDY CytoDyn Inc
05/11/2020 6:18:05 PM
"benefit of the doubt"...yes, in th
CYDY CytoDyn Inc
05/11/2020 5:04:01 PM
I'm with you, Jim. The perpetual no
CYDY CytoDyn Inc
05/10/2020 7:48:46 PM
yes, annoying. (1)
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • Lead Pollution's Lasting Impact on Memory and Alzheimer's Risk
  • Key Stock Insights: Amazon's Buy Potential and Starbucks Risks
  • Urgent Solutions to America's Workforce Crisis: New Book Insights
  • Remittix Prepares for Innovative Crypto Wallet Launch in 2025
  • Countdown to CIIE: Global Businesses Prep for New Opportunities
  • Unlocking America’s Mineral Wealth: Insights from a Pentagon Insider
  • Reviving Lost Crypto: The Journey of a Bitcoin Recovery Expert
  • Brittany Force Achieves Historic NHRA Speed Record of 343.16 MPH
  • Reza Pahlavi Reports Surge in Support from Iranian Defectors
  • Sling Pilot Academy Joins Forces with Sallie Mae for Financing
  • Expansion of Precision Global Corporation with CubeSmart Partnership
  • Precision Global Corporation and CubeSmart Join Forces for Growth
  • Trump's Administration Investments: A Long-Term Shift in Strategy
  • Robert Kiyosaki Compares ETFs to Pictures of Guns, Advocates for Real Assets
  • Justice Department's Decision Sparks Controversy Over Attorney Dismissal
  • Elon Musk's Surprising View on AI and Rising Birth Rates
  • How the Wealthy Diversify: Watches, Diamonds, and the Rise of Collectible Assets
  • Independent Voter Sentiment Shifts Significantly for Trump
  • Massive Bitcoin Movement Shakes Crypto Markets After Years
  • Senator Lummis Advocates Bitcoin: A Vision for Economic Freedom
  • TDECU and C.J. Stroud Unite to Promote Financial Literacy
  • Dogecoin's Potential Surge: A Historic Buying Opportunity
  • Revolutionizing Startup Software Development with AI Solutions
  • Secure Your Rights: Join WAMCO Class Action Lawsuit Today
  • GeneDx Holdings Corp: Investigating Investor Rights Concerns
  • Rosen Law Firm Invites Investors in Rocket Pharmaceuticals to Act
  • Donald Trump's Scottish Visit: Golf, Legacy, and Diplomacy
  • From Credit Dips to Dividend Tips: When an Online Loan Makes Sense
  • Understanding the Pink Salt Trend and Its Health Implications
  • WeRide and Chery Join Forces to Launch Global Robotaxi Services
  • Investor Challenges Tencent Music's Acquisition of Ximalaya Inc.
  • How To Choose The Right Software Solution For Your Business?
  • American Progress: President Trump's Administration Updates
  • Unlock Potential with BexBack's 100x Crypto Leverage
  • WeRide's New Robotaxi Permit: A Step Towards Smart Mobility
  • Jamie Dimon Reflects on Dismissal and Family's Support
  • America's Journey to Stardom: Insights from President Trump
  • Biohaven Securities Fraud Lawsuit: Join the Action Today
  • Injury Lawsuits Can Sink More Than Morale—They Can Tank Your Assets
  • Exploring America's Hidden Mineral Rush Beneath the Surface
  • Key Developments for Rocket Pharmaceuticals Investors
  • Discover the KatuChef Cutting Board: Kitchen Innovation Redefined
  • Neogen Corporation Faces Class Action Amid Financial Challenges
  • Explore TWOPAGES' Trendsetting Insights for Home Décor in 2025
  • Celebrating Coinchange's Growth: A Journey to Institutional Finance
  • Unlocking the Future: The Final Hours of Bitcoin Swift Presale
  • Bitcoin Swift Set to Conclude Stage 1 Presale with Unique Features
  • RxSight, Inc. Investors Have Chance to Lead Class Action Lawsuit
  • Anthony Scaramucci Commends Trump's Political Comeback and Insights
  • Investigation of National Grid plc Sparks Interest Among Investors
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site